- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT05983185
Terapia di adattamento del prisma (PAT) per la riabilitazione dell'ictus cerebrale destro
Trattamento di adattamento del prisma (PAT) per la riabilitazione dell'ictus cerebrale destro
After a right brain stroke, >50% of Veterans experience problems with dressing, eating, self-care or steering their wheelchairs because their ability to move, orient, and respond toward the left side is limited: spatial neglect. Spatial neglect prevents them from functioning independently, and their needs in the hospital and at home are greatly increased. An effective treatment for spatial neglect is 10 days of visuomotor training while wearing optical prisms (PAT), however many clinicians [fail to diagnose spatial neglect and use this approach. In this study, the investigators will develop a brain scanning test that could objectively identify the Veterans with spatial neglect after stroke who are the best candidates to receive PAT and recover their ability to function. When the research is complete, the investigators expect that brain scans done in the hospital can guide the team to refer Veterans to PAT rehabilitation: improving daily life function] and quality of life.
Panoramica dello studio
Stato
Intervento / Trattamento
Descrizione dettagliata
Project Summary/Abstract The application addresses the formidable treatment gap for cognitive rehabilitation of spatial neglect (SN), defined as asymmetric orienting, perception, and responding to left space after right brain stroke, causing functional disability. Although Veterans with SN are half as likely to return home, have one-third the community mobility, require 3x as much caregiver supervision, and have longer hospitalizations, increased fall risk and increased rehospitalization compared with similar right brain stroke survivors, a personalized approach to SN rehabilitation is not available in Veteran-specific systems of care. The investigators discovered that frontal lobe damage and "Aiming" SN both predict optimal recovery of functional independence after prism adaptation treatment (PAT). These findings argue for the development of an [objective, biomarker-based process to identify patients who should be administered PAT. The algorithm will be developed by identifying specific neurobiological features predictive of PAT treatment response. Thus, the investigators expect this research will deliver a critical missing element to rehabilitation, eliminating clinician uncertainty about SN diagnosis and appropriateness of PAT, and allowing a more personalized health care approach to SN rehabilitation. The team of researchers at three high-performing VA medical centers, distinguished in cognitive neurology analysis of brain imaging predictors, and stroke rehabilitation, from both advanced and clinical data, will develop the first biological parameter that can be used to assign SN rehabilitation. In 180 Veterans (120 with SN, 60 without), the investigators will define and validate brain imaging biomarkers that predict the presence of Aiming SN (Aim 1), a strong predictor of functional recovery after receiving PAT. The expectation that disconnection of frontal regions with subcortical and parietal regions will predict Aiming SN. The investigators will also examine the correlation between the brain imaging biomarkers predicting Aiming SN and improvements in daily life function after PAT (Aim 2).] Then, the investigators will determine if adding behavioral predictors to biomarker predictors (Aim 3) accounts for additional variance in the trajectory of functional recovery. The overall impact of the investigators' work will be to establish the utility of a validated biomarker that routinely identifies Veterans with SN after stroke who are the best candidates for PAT. Armed with a biomarker-based algorithm, the investigators can then carry out a large-scale PAT clinical trial, and personalized SN care. This care pathway could reduce reliance on specialized SN assessment, [coordinate VA and community systems providing Veteran stroke care,] and improve stroke care efficiency, to enhance outcomes and quality of life after stroke for thousands of Veterans.
Tipo di studio
Iscrizione (Stimato)
Fase
- Non applicabile
Contatti e Sedi
Contatto studio
- Nome: Anna M Barrett, MD
- Email: Anna.Barrett2@va.gov
Backup dei contatti dello studio
- Nome: Akila Sanjay, BA
- Numero di telefono: (508) 856-0104
- Email: akila.sanjay@va.gov
Luoghi di studio
-
-
Connecticut
-
West Haven, Connecticut, Stati Uniti, 06516-2770
- Reclutamento
- VA Connecticut Healthcare System West Haven Campus, West Haven, CT
-
Contatto:
- Sharon Bottomley, DNP
- Numero di telefono: 203-932-5711
- Email: sharon.bottomley@va.gov
-
Contatto:
- Nishant Mishra, MD
- Numero di telefono: 6504408349
- Email: nishant.mishra@va.gov
-
-
Georgia
-
Decatur, Georgia, Stati Uniti, 30033-4004
- Reclutamento
- Atlanta VA Medical and Rehab Center, Decatur, GA
-
Contatto:
- Michael Dattilo, MD
- Numero di telefono: 20660 4043216111
- Email: michael.datillo@va.gov
-
Contatto:
- Mychaela Eatmon
- Numero di telefono: 404-725-3256
- Email: mychaela.eatmon@va.gov
-
-
Massachusetts
-
Leeds, Massachusetts, Stati Uniti, 01053-9764
- Reclutamento
- VA Central Western Massachusetts Healthcare System, Leeds, MA
-
Investigatore principale:
- Anna M. Barrett, MD
-
Contatto:
- Anna M Barrett, MD
- Email: Anna.Barrett2@va.gov
-
Contatto:
- Emily Muller, BA
- Numero di telefono: 508-254-7217
- Email: emily.muller@umassmed.edu
-
-
Ohio
-
Cleveland, Ohio, Stati Uniti, 44106-1702
- Reclutamento
- Louis Stokes VA Medical Center, Cleveland, OH
-
Contatto:
- Jessica McCabe, PT
- Numero di telefono: 8203830 216-791-3800
- Email: jessica.mccabe@va.gov
-
Contatto:
- Svetlana Pundik
- Numero di telefono: 63732 2167913800
- Email: svetlana.pundik@va.gov
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- Has had a first right brain stroke >18 years of age
- 1-4 months post-diagnosis of right brain stroke
- Can sit up, see out of both eyes and point to objects (>20/50 vision in both eyes)
- Can give informed consent to participate
Exclusion Criteria:
- Has been diagnosed with other chronic, disabling neurological disorder (e.g. multiple sclerosis, Alzheimer Disease)
- Has had a clinical left brain stroke or has neuroimaging evidence of prior stroke(s) including the presence of more than two lacunes with diameter greater than 15 mm.
- Cannot sit up to be tested and receive PAT
- Has <20/50 vision when viewing with both eyes
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Diagnostico
- Assegnazione: Non randomizzato
- Modello interventistico: Assegnazione di gruppo singolo
- Mascheramento: Separare
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Comparatore attivo: Prism adaptation Therapy
People with spatial neglect will receive this effective treatment to reduce symptoms, which the investigators' previous work indicated may be particularly effective for Aiming SN symptoms. |
The investigators' research and clinical group is the US leader in implementing this intervention for spatial neglect and have brought it to more than 50 clinical centers, hospitals, and treatment organizations.
Altri nomi:
|
|
Nessun intervento: No spatial neglect
People without spatial neglect symptoms will not receive an intervention for spatial neglect. |
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Spatial neglect (SN) type (Aiming SN versus Where SN)
Lasso di tempo: baseline
|
This variable is assignment to category defining spatial neglect. This is based on a data collection with computerized line bisection, which generates a profile score. Veterans whose computerized line bisection profile score indicates that they have spatial neglect that primarily affects movement, intention and action have Aiming SN; these Veterans responded best to prism adaptation therapy (PAT) in prior research. Alternately, Veterans may have a profile score consistent with Where SN, affecting perception and action. |
baseline
|
|
Functional independence Measure (FIM) improvement trajectory
Lasso di tempo: 5 weeks after enrollment
|
This outcome variable measures how well Veterans can carry out their daily life self-care activities independently on a validated measure, the Functional Independence Measure (FIM). |
5 weeks after enrollment
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
SN severity, as assessed by the Behavioral Inattention Test-conventional subtest (BIT-c)
Lasso di tempo: 5 weeks after enrollment
|
This variable examines the severity of spatial neglect as measured by functionally-valid assessment, the Behavioral Inattention Test-conventional subtest (BIT-c; max value 146, min value 0, lower is abnormal). Functionally-valid spatial neglect assessments predict independence for activities of daily living, and care needs. |
5 weeks after enrollment
|
|
SN severity, as assessed by the Catherine Bergego Scale (CBS)
Lasso di tempo: 5 weeks after enrollment
|
This variable (max value 30, min value 0, higher is abnormal) examines the severity of spatial neglect as measured by a functionally-valid assessment, the CBS. Functionally-valid spatial neglect assessments predict independence for activities of daily living, and care needs. |
5 weeks after enrollment
|
Collaboratori e investigatori
Investigatori
- Investigatore principale: Anna M. Barrett, MD, VA Central Western Massachusetts Healthcare System, Leeds, MA
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Stimato)
Completamento dello studio (Stimato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Altri numeri di identificazione dello studio
- C3662-R
- 1I01RX003662-01A1 (Sovvenzione/contratto NIH degli Stati Uniti)
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
prodotto fabbricato ed esportato dagli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .